Etrabamine

Etrabamine Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +8613564774135
Email: zijue.cai@tsbiochem.com
Products Intro: Product Name:Etrabamine
CAS:70590-58-8
Package:100mg;2500USD|25mg;1520USD|50mg;1980USD
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:Etrabamine
CAS:70590-58-8
Package:100mg/RMB 17500;25mg/RMB 10600;50mg/RMB 13800
Company Name: Lanospharma Laboratories Co.,Ltd  
Tel: 13440048448
Email: sales@lanospharma.com
Products Intro:

Etrabamine manufacturers

  • Etrabamine
  • Etrabamine pictures
  • $2500.00 / 100mg
  • 2024-10-28
  • CAS:70590-58-8
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
Etrabamine Basic information
Product Name:Etrabamine
Synonyms:Etrabamine;6-Benzothiazolamine, 4,5,6,7-tetrahydro-N-methyl-
CAS:70590-58-8
MF:C8H12N2S
MW:168.26
EINECS:
Product Categories:
Mol File:70590-58-8.mol
Etrabamine Structure
Etrabamine Chemical Properties
Safety Information
MSDS Information
Etrabamine Usage And Synthesis
Etrabamine Preparation Products And Raw materials
Tag:Etrabamine(70590-58-8) Related Product Information
Pramipexole 2-Amino-6-phthalimido-4,5,6,7-tetrahydro benzothiazole N-(2-AMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOL-6-YL)-PROPIONAMIDE Pramipexole EP Impurity E (R)-N-(2-AMINO-4,5,6,7-TETRAHYDRO-BENZOTHIAZOL-6-YL)-PROPIONAMIDE Pramipexole dihydrochloride monohydrate PRAMIPEXOLE-D3, DIHYDROCHLORIDE Pramipexole dihydrochloride (-)-2-Amino-6-propionamido-tetrahydro-benzothiazole-D3 6-Acetamido-2-amino-4,5,6,7-tetrahydrobenzothiazole PRAMIPEXOLE-D5 DIHCL Etrabamine

This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept